Cancer Management and Research
Association of Peri-Neoadjuvant Chemotherapy Hemoglobin, Albumin, Lymphocyte, and Platelet Score with Complete Gross Resection at Interval Debulking Surgery in Advanced Ovarian Cancer: An Exploratory Retrospective Cohort Study
By Hao Su, Mingle Tian, Yongxue Wang and 5 others.
Abstract
Introduction
Complete gross resection (CGR) at interval debulking surgery (IDS) is a critical surgical endpoint in ovarian cancer, but its likelihood remains difficult to estimate before surgery in patients treated with neoadjuvant chemotherapy (NACT). The hemoglobin, albumin, lymphocyte, and platelet (HALP) score integrates nutritional, inflammatory, immune, and anemia-related status, but its association with CGR after NACT remains unclear. This study evaluated the association of peri-NACT HALP with CGR at IDS.
